President & CSO Stephen Connelly files to sell $632K in shares
EQ has more than doubled off its 52-week low of $0.27 on elevated volume (2.8× avg).
Summary
Equillium's President and CSO, Stephen Connelly, intends to sell over $632,000 worth of common stock, marking a notable insider disposition.
Key Events · Ownership and Investor Activity · EQ
-
Officer Files Intent to Sell Shares
Stephen Connelly, President and CSO, filed a Form 144 to sell 200,000 shares of common stock.
-
Significant Value of Proposed Sale
The proposed sale is valued at approximately $632,760, representing 0.32% of the company's current market capitalization.
-
Adds to Insider Distribution Trend
This filing contributes to a recent pattern of insider sales, with over $1.45 million in net sales by insiders in the last 90 days.
-
Long-Held Founders Shares
The shares intended for sale were acquired as founders shares in May 2017, indicating a disposition of long-term holdings.
Analysis · EQ · Life Sciences
Stephen Connelly, President and CSO, has filed a Form 144 indicating his intent to sell 200,000 shares, valued at approximately $632,760. This represents a significant disposition by a key executive, following recent capital raises and shareholder approval for a reverse stock split. The sale adds to a recent trend of insider distribution.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EQ was trading at $3.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $200.4M. The 52-week trading range was $0.27 to $3.45. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.